Principal Investigator
Magdalena Tolea
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20230676
Clinical Trial Summary
A Phase 2b Clinical Study of the P38 Alpha Kinase Inhibitor
Neflamapimod in Patients with Dementia with Lewy Bodies (DLB)
Phase
TBD
Funding Agency/Sponsor
Intramural
Disease
Other